Did you know over 2.7 million laparoscopy procedures are performed every year in the United States? Laparoscopy is continually developing towards being the least invasive approach to surgery. It had originally emerged to address complications and improve the outcomes of open surgery and is now moving towards being the most advanced robotic-assisted surgery. Many of
Based on the recent market study performed by iData Research, over 13 million laparoscopic procedures are performed globally every year. Laparoscopy is a minimally invasive surgical procedure that allows a surgeon to access the inside of the abdomen and pelvis through small incisions, (5mm-15mm) eliminating the need for large incisions in the skin. Laparoscopy, also
Based on the latest Laparoscopic Devices market analysis by iData Research, there are over 2.5 million laparoscopic surgeries performed in the US every year. Laparoscopy remains one of the most common minimally invasive surgical techniques, providing benefits of faster patient recovery, shorter hospital stays, and fewer post-operative complications. However, in the light of the COVID19
KARL STORZ, the leading endoscopy manufacturer, and VirtaMed, a world leader in surgical simulators for medical education, release a mixed reality simulator set to revolutionize laparoscopy training. The LapTrainer allows medical students and professionals to practice key skills such as patient positioning, trocar placement, and how to prepare the OR team under realistic conditions. The
Register to receive a free synopsis and brochure. Browse the Report Library ConMed’s history began in 1970, when they were first established by Eugene Corasanti in Utica, New York as Consolidated Medical Equipment, Inc. Today, it is a leading global medical technology company in the United States. The business operates in a range of categories, including: arthroscopy,
Register to receive a free U.S. Market Report Suite for Laparoscopic Devices – MedSuite report synopsis and brochure TransEnterix, Inc., a medical technology company in the laparoscopic devices industry announced that it has received Japanese regulatory approval for the Senhance™ Surgical System on May 28th, 2019. TransEnterix is working to digitize the interface between surgeons and patients
Register to receive a free U.S. Market Report Suite for Laparoscopic Devices – MedSuite report synopsis and brochure ReShape Lifesciences, a prominent company in the gastric device market, has exhibited their LAP-BAND technology for the first time since its acquisition. The LAP-BAND was shown at the Minimally Invasive Surgery Symposium (MISS) in Las Vegas from February 25-28,
Register to receive a free U.S. Market Report Suite for Laparoscopic Devices – MedSuite report synopsis and brochure Recently, Apollo Endosurgery, Inc. announced the sale of its surgical product line to ReShape Lifesciences. On December 17, 2018, the transaction agreements were signed and closed simultaneously. Apollo is an international leader in minimally invasive medical devices for gastrointestinal
Register to receive a free U.S. Market Report Suite for Laparoscopic Devices – MedSuite report synopsis and brochure TransEnterix, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced that the Company received FDA 510(k) clearance for 3 millimeter diameter instruments, as well as additional
Register to receive a free U.S. Market Report Suite for Laparoscopic Devices – MedSuite report synopsis and brochure Apollo Endosurgery, Inc. (“Apollo”), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced completion of enrollment in the ORBERA® Post Approval Study evaluating the ORBERA intragastric balloon. The ORBERA Post Approval Study is
